Global Medical REIT Inc. Stock: price and insider trades · United States · SEC (Form 4)Track the Global Medical REIT Inc. share price and the full insider trade history of the company, a listed issuer based in United States. Shares are listed on the US market, under the supervision of SEC (Form 4). Operating in the Real Estate sector, Global Medical REIT Inc. has recorded 14 reports. The latest transaction was disclosed on 8 December 2025 (Acquisition). Among the most active insiders: Decker Mark Okey Jr. Every trade is free.
€784,641
2 ops.
Sell Volume
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Σ Sigma AI Analysis Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 8 December 2025
All Executives14 Thresholds0 Prospectus0 Other0
Declarations 14 total
▲ CEO and President · Executives · 5 Dec 2025
10,000 shares @ US$32.51 26.9% of flow Common Stock SEC:0001104659-25-119306:0
Canonical exit: 5 Mar 2026 (T+90) ▲ CFO and Treasurer · Executives · 14 Nov 2025
3,000 shares @ US$31.91 100.0% of flow Common Stock SEC:0001104659-25-113328:0
Canonical exit: 12 Feb 2026 (T+90) ▲ CEO and President · Executives · 14 Nov 2025
4,093 shares @ US$32.41 15.1% of flow Common Stock SEC:0001104659-25-113327:0
Canonical exit: 12 Feb 2026 (T+90) ▲ Director · Executives · 26 Aug 2025
1,350 shares @ US$7.3781 100.0% of flow Common Stock SEC:0001104659-25-083143:0
Canonical exit: 24 Nov 2025 (T+90) ▼ General Counsel and Secretary · Executives · 15 Aug 2025
130,000 shares @ US$6.6236 100.0% of flow Common Stock SEC:0001104659-25-079799:0
▲ CEO and President · Executives · 15 Aug 2025
13,871 shares @ US$6.84 12.7% of flow Common Stock SEC:0001104659-25-079792:0
Canonical exit: 13 Nov 2025 (T+90) ◇ General Counsel and Secretary · Executives · 7 Aug 2025
130,000 shares Common Stock SEC:0001104659-25-075670:0
▲ CEO and President · Executives · 24 Jun 2025
100,000 shares @ US$6.527 100.0% of flow Common Stock SEC:0001104659-25-062678:0
Canonical exit: 22 Sept 2025 (T+90) ◇ Director · Executives · 30 Jan 2023
7,412 shares Common Stock SEC:0001104659-23-008590:0
▼ Director · Executives · 10 Jan 2023
5,000 shares @ US$9.7913 100.0% of flow Common Stock SEC:0001104659-23-002707:0
◇ Director · Executives · 29 Mar 2022
5,000 shares Common Stock SEC:0001104659-22-040111:0
▲ Director · Executives · 4 Mar 2022
1,287 shares @ US$15.5396 100.0% of flow Common Stock SEC:0001104659-22-031579:0
Canonical exit: 2 Jun 2022 (T+90) ▲ Chairman, President and CEO · Executives · 3 Mar 2022
2,000 shares @ US$15.55 52.1% of flow Common Stock SEC:0001104659-22-030737:0
Canonical exit: 1 Jun 2022 (T+90) ▲ Chairman, President and CEO · Executives · 19 Aug 2021
1,000 shares @ US$15.01 31.5% of flow Common Stock SEC:0001104659-21-108231:0
Canonical exit: 17 Nov 2021 (T+90) 关于 Global Medical REIT Inc. Global Medical REIT Inc. 是一家专业医疗保健房地产投资信托基金,在纽约证券交易所上市,股票代码为 GMRE,总部位于美国马里兰州贝塞斯达。该公司专注于收购医疗设施并将其租赁给医生团体以及区域和国家医疗保健系统。对于国际股票投资者而言,它提供了一种专注于美国医疗房地产的投资方式,该领域通常被视为相对防御性,因为对医疗保健服务的需求比许多其他房地产类型更少周期性。同时,该业务仍然对融资条件、租户信用质量和资本配置纪律敏感。
GMRE 的核心模式很简单:购买医疗物业,签订长期租赁合同,并产生经常性租金收入。其投资组合集中在医疗保健相关资产,包括与心脏病学、胃肠病学、影像学和肿瘤学等程序性专科相关的设施。该公司强调,其许多租赁合同都采用三净租赁结构,这通常将大部分物业层面的费用转移给租户,并支持利润稳定性。投资案例的一个关键部分是资产的战略性布局,靠近医院园区或位于与租户运营和患者流量高度匹配的地点。这种邻近性有助于支持租户保留和长期入住率。
从业务历史的角度来看,Global Medical REIT 已将其平台建设成为一家专业的医疗 REIT,而非一家广泛的物业所有者。该公司奉行一种投资组合策略,将收购创收设施与选择性处置非核心资产相结合。最近的公司更新显示,它在资本配置的两方面都保持活跃。2025 年初,该公司完成了此前宣布的五处物业组合的收购,同时处置了两处医疗设施。2025 年晚些时候,它报告了进一步的收购和处置活动,表明其正在持续努力将资本再循环到更符合其长期战略的资产中。这些行动很重要,因为投资组合质量和资产组合是 REIT 估值的核心。
在竞争方面,GMRE 在一个专业化至关重要的市场中运营。规模更大的多元化 REIT 可能拥有更广泛的规模,但 GMRE 更狭窄的重点使其能够追求其充分了解租户概况的医疗保健资产。其市场地位较少依赖品牌知名度,更多依赖于承保纪律、获得有吸引力的交易流以及有效融资增长的能力。投资者通常在评估像 GMRE 这样的公司时会关注 AFFO 趋势、杠杆、派息政策和同店运营业绩。最近的公司通讯也提到了重申的 2025 年 AFFO 指导和股息声明,这两者都与以收入为导向的股东相关。
总而言之,Global Medical REIT Inc. 在美国纽约证券交易所提供了一个集中的美国医疗保健房地产投资主题。该公司结合了经常性租金收入、对关键医疗物业的重视以及积极的投资组合管理。对于法语投资者而言,最好将其视为一家拥有相对防御性终端市场的专业医疗物业所有者,但仍需密切关注资产负债表实力和资本部署。